198 related articles for article (PubMed ID: 1274591)
21. [Blood cell concentration of methotrexate in long-term therapy of inflammatory rheumatic diseases].
Leeb B; Dunky A; Ogris E; Wohanka A; Schenk G; Fischer M; Tausch G; Eberl R
Acta Med Austriaca; 1988; 15(5):140-4. PubMed ID: 3146207
[TBL] [Abstract][Full Text] [Related]
22. Methotrexate-induced cirrhosis requiring liver transplantation in three patients with psoriasis. A word of caution in light of the expanding use of this 'steroid-sparing' agent.
Gilbert SC; Klintmalm G; Menter A; Silverman A
Arch Intern Med; 1990 Apr; 150(4):889-91. PubMed ID: 2327848
[TBL] [Abstract][Full Text] [Related]
23. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
vanDooren-Greebe RJ; Kuijpers AL; Buijs WC; Kniest PH; Corstens FH; Nagengast FM; de Boo T; Willems JL; Duller P; van de Kerkhof PC
Br J Dermatol; 1996 Mar; 134(3):481-7. PubMed ID: 8731673
[TBL] [Abstract][Full Text] [Related]
24. Galactose tolerance test and methotrexate-induced liver fibrosis and cirrhosis in patients with psoriasis.
Lenler-Petersen P; Søgård H; Thestrup-Pedersen K; Zachariae H
Acta Derm Venereol; 1982; 62(5):448-9. PubMed ID: 6183903
[TBL] [Abstract][Full Text] [Related]
25. Psoriatic arthritis: clinical response and side effects to methotrexate therapy.
Espinoza LR; Zakraoui L; Espinoza CG; Gutiérrez F; Jara LJ; Silveira LH; Cuéllar ML; Martínez-Osuna P
J Rheumatol; 1992 Jun; 19(6):872-7. PubMed ID: 1404123
[TBL] [Abstract][Full Text] [Related]
26. Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate.
Rau R; Karger T; Herborn G; Frenzel H
J Rheumatol; 1989 Apr; 16(4):489-93. PubMed ID: 2473207
[TBL] [Abstract][Full Text] [Related]
27. Methotrexate hepatotoxicity in psoriatic patients submitted to long-term therapy.
Themido R; Loureiro M; Pecegueiro M; Brandão M; Campos MC
Acta Derm Venereol; 1992 Sep; 72(5):361-4. PubMed ID: 1361285
[TBL] [Abstract][Full Text] [Related]
28. Sequential liver biopsies during long-term methotrexate treatment for psoriasis: a reappraisal.
Boffa MJ; Chalmers RJ; Haboubi NY; Shomaf M; Mitchell DM
Br J Dermatol; 1995 Nov; 133(5):774-8. PubMed ID: 8555032
[TBL] [Abstract][Full Text] [Related]
29. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
Luis M; Pacheco-Tena C; Cazarín-Barrientos J; Lino-Pérez L; Goycochea MV; Vazquez-Mellado J; Burgos-Vargas R
Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
[TBL] [Abstract][Full Text] [Related]
30. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
[TBL] [Abstract][Full Text] [Related]
31. Morphogenesis of fibrosis and cirrhosis in methotrexate-treated patients with psoriasis.
Nyfors A; Poulsen H
Am J Surg Pathol; 1977 Sep; 1(3):235-43. PubMed ID: 920871
[TBL] [Abstract][Full Text] [Related]
32. Detection of significant liver fibrosis in Chinese psoriasis patients receiving methotrexate: a comparison between transient elastography and liver histology.
Wong CSM; Mak LLY; Lee VKH; Lo RCL; Chung MMH; Chu F; Yeung CK; Yuen MF; Chan HHL
Hong Kong Med J; 2024 Apr; 30(2):110-119. PubMed ID: 38651202
[TBL] [Abstract][Full Text] [Related]
33. A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis.
Mathew J; Leong MY; Morley N; Burt AD
BMC Dermatol; 2005 Nov; 5():12. PubMed ID: 16316460
[TBL] [Abstract][Full Text] [Related]
34. The relation of HL-A antigens to liver histology in methotrexate-treated psoriatics.
Nyfors A; Svejgaard A
Acta Derm Venereol; 1976; 56(3):235-8. PubMed ID: 59509
[TBL] [Abstract][Full Text] [Related]
35. Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients.
Boffa MJ; Smith A; Chalmers RJ; Mitchell DM; Rowan B; Warnes TW; Shomaf M; Haboubi NY
Br J Dermatol; 1996 Oct; 135(4):538-44. PubMed ID: 8915142
[TBL] [Abstract][Full Text] [Related]
36. Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury.
Langman G; Hall PM; Todd G
J Gastroenterol Hepatol; 2001 Dec; 16(12):1395-401. PubMed ID: 11851839
[TBL] [Abstract][Full Text] [Related]
37. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
Lanse SB; Arnold GL; Gowans JD; Kaplan MM
Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
[TBL] [Abstract][Full Text] [Related]
38. Methotrexate-induced liver cirrhosis. Clinical, histological and serological studies--a further 10-year follow-up.
Zachariae H; Søgaard H; Heickendorff L
Dermatology; 1996; 192(4):343-6. PubMed ID: 8864370
[TBL] [Abstract][Full Text] [Related]
39. Liver biopsies from psoriatics treated with methotrexate.
Ho MS; Cheah E; Tham SN; Teh LB; Ng HS; Thirumoorthy S
Ann Acad Med Singap; 1986 Apr; 15(2):210-4. PubMed ID: 3752896
[TBL] [Abstract][Full Text] [Related]
40. Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples.
Kremer JM; Lee RG; Tolman KG
Arthritis Rheum; 1989 Feb; 32(2):121-7. PubMed ID: 2920047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
